Serious adverse events (3 to 4 weeks · children with stable wrist fracture, predominantly buckle (torus) fracturesa
1 finding from 1 review
Return to normal activities (days) · children with stable wrist fracture, predominantly buckle (torus) fracturesa
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain intensity VAS (0 to 100; 0 = no pain, 100 = worst pain) · children with stable wrist fracture, predominantly buckle (torus) fracturesa
1 finding from 1 review
Minor complications (3 to 6 weeks · children with stable wrist fracture, predominantly buckle (torus) fracturesa
1 finding from 1 review
Participant satisfaction: children found treatment was convenient (4 weeks · children with stable wrist fracture, predominantly buckle (torus) fracturesa
It is very uncertain whether summary of findings. Bandage changes participant satisfaction: children found treatment was convenient (4… compared with cast (very low certainty).
1 finding from 1 review
Physical function · children with stable wrist fracture, predominantly buckle (torus) fracturesa
It is very uncertain whether summary of findings. Bandage changes physical function (short‐term): no problems or only 'limited… compared with cast (very low certainty).
1 finding from 1 review
Treatment failure: (3 to 6 weeks · children with stable wrist fracture, predominantly buckle (torus) fracturesa
It is very uncertain whether summary of findings. Bandage changes treatment failure: (3 to 6 weeks compared with cast (very low certainty).
1 finding from 1 review
Symptomatic improvement · mostly women with dry eye syndrome
1 finding from 1 review
Ocular surface staining · mostly women with dry eye syndrome
1 finding from 1 review
Aqueous tear production · mostly women with dry eye syndrome
1 finding from 1 review
Tear film stability · mostly women with dry eye syndrome
1 finding from 1 review
Artificial tear use · mostly women with dry eye syndrome
1 finding from 1 review
Adverse events · mostly women with dry eye syndrome
1 finding from 1 review
Mortality attributable to hepatic veno‐occlusive disease ( · People undergoing autologous or HLA identical allogeneic bone marrow transplant with a variety of malignant diseases or aplastic anaemia
Summary of findings: Heparin showed no clear difference in mortality attributable to hepatic veno‐occlusive disease ( compared with no treatment (low certainty).
1 finding from 1 review
Quality of life · People undergoing autologous or HLA identical allogeneic bone marrow transplant with a variety of malignant diseases or aplastic anaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Frequency of adverse events ( · People undergoing autologous or HLA identical allogeneic bone marrow transplant with a variety of malignant diseases or aplastic anaemia
It is very uncertain whether summary of findings: Heparin changes frequency of adverse events ( compared with no treatment (very low certainty).
1 finding from 1 review
Incidence of hepatic veno‐occlusive disease ( · Patients undergoing stem cell transplant with malignant and non‐malignant diseases
It is very uncertain whether summary of findings: Heparin changes incidence of hepatic veno‐occlusive disease ( compared with low molecular weight heparin (very low certainty).
1 finding from 1 review
Overall survival · Patients undergoing stem cell transplant with malignant and non‐malignant diseases
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality at 100 days post‐transplant · Patients undergoing stem cell transplant with malignant and non‐malignant diseases
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality attributable to hepatic veno‐occlusive disease ( · Patients undergoing stem cell transplant with malignant and non‐malignant diseases
It is very uncertain whether summary of findings: Heparin changes mortality attributable to hepatic veno‐occlusive disease ( compared with low molecular weight heparin (very low certainty).
1 finding from 1 review